IE
FLNA

Israel Englander’s Filana Therapeutics FLNA Stock Holding History

Israel Englander’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-90,900
Closed -$215K – 6340
2024
Q4 		$215K Buy
+90,900
New +$1.6M ﹤0.01% 5273
2021
Q2 		– Sell
-20,000
Closed -$899K – 7039
2021
Q1 		$899K Buy
+20,000
New +$787K ﹤0.01% 4327

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Israel Englander's FLNA Position: Q2 2026 in Review

Israel Englander sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 72,588 shares — an estimated $123K sold.

Israel Englander first reported a position in FLNA in Q2 2013 and held it in 23 quarters. The position peaked at $10.3M in Q1 2021. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Israel Englander reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 72,588 Filana Therapeutics shares in Q2 2026, an estimated $123K.
  • Israel Englander first reported a position in Filana Therapeutics in Q2 2013 and held it in 23 quarters.
  • Israel Englander's Filana Therapeutics position peaked at $10.3M in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.